These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7825771)

  • 1. Atovaquone for Pneumocystis carinii pneumonia.
    Lederman MM; van der Horst C
    Ann Intern Med; 1995 Feb; 122(4):314; author reply 314-5. PubMed ID: 7825771
    [No Abstract]   [Full Text] [Related]  

  • 2. Atovaquone for Pneumocystis carinii pneumonia.
    Stoeckle M; Tennenberg A
    Ann Intern Med; 1995 Feb; 122(4):314; author reply 314-5. PubMed ID: 7825772
    [No Abstract]   [Full Text] [Related]  

  • 3. Atovaquone as prophylaxis for Pneumocystis carinii.
    Vilar FJ; McKendrick MW; Nash C
    Int J STD AIDS; 1996 Jul; 7(4):302. PubMed ID: 8876368
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current alternatives in the treatment of Pneumocystis carinii pneumonia in patients with AIDS].
    Pastor C; Lumbreras C; Lizasoain M
    Med Clin (Barc); 1994 Oct; 103(12):473-6. PubMed ID: 7996899
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy and prevention of pneumocystis carinii pneumonia].
    Goebel FD; Bogner JR
    Internist (Berl); 1995 Dec; 36(12):1150-5. PubMed ID: 8567220
    [No Abstract]   [Full Text] [Related]  

  • 6. Atovaquone suspension for treatment of Pneumocystis carinii pneumonia in HIV-infected patients.
    Rosenberg DM; McCarthy W; Slavinsky J; Chan CK; Montaner J; Braun J; Dohn MN; Caldwell PT
    AIDS; 2001 Jan; 15(2):211-4. PubMed ID: 11216929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mepron for AIDS-related pneumonia.
    Am Pharm; 1993 Mar; NS33(3):14-5. PubMed ID: 8475842
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS.
    Hughes W; Leoung G; Kramer F; Bozzette SA; Safrin S; Frame P; Clumeck N; Masur H; Lancaster D; Chan C
    N Engl J Med; 1993 May; 328(21):1521-7. PubMed ID: 8479489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Atovaquone Study Group.
    Dohn MN; Weinberg WG; Torres RA; Follansbee SE; Caldwell PT; Scott JD; Gathe JC; Haghighat DP; Sampson JH; Spotkov J; Deresinski SC; Meyer RD; Lancaster DJ
    Ann Intern Med; 1994 Aug; 121(3):174-80. PubMed ID: 7880228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atovaquone as prophylaxis against Pneumocystis carinii pneumonia.
    Fisher MJ; Gazzard BG; Hawkins DA; Nelson MR
    J Infect; 1994 Jan; 28(1):103-4. PubMed ID: 8163822
    [No Abstract]   [Full Text] [Related]  

  • 11. Overdose of atovaquone in a patient with AIDS.
    Cheung TW
    AIDS; 1999 Oct; 13(14):1984-5. PubMed ID: 10513663
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of atovaquone tablets in treating Pneumocystis carinii pneumonia.
    Hughes WT
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Mar; 8(3):247-52. PubMed ID: 7859136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with atovaquone: a new drug for treating Pneumocystis carinii pneumonia.
    Epstein LJ; Mohsenifar Z; Daar ES; Yeh V; Meyer RD
    Am J Med Sci; 1994 Jul; 308(1):5-8. PubMed ID: 8010339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new drug (566C80) for the treatment of Pneumocystis carinii pneumonia.
    Hughes WT
    Ann Intern Med; 1992 Jun; 116(11):953-4. PubMed ID: 1580456
    [No Abstract]   [Full Text] [Related]  

  • 15. Vortex keratopathy associated with atovaquone.
    Shah GK; Cantrill HL; Holland EJ
    Am J Ophthalmol; 1995 Nov; 120(5):669-71. PubMed ID: 7485371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atovaquone for Pneumocystis carinii pneumonia.
    Med Lett Drugs Ther; 1993 Apr; 35(893):28-9. PubMed ID: 8450807
    [No Abstract]   [Full Text] [Related]  

  • 17. Atovaquone to be marketed as oral therapy for Pneumocystis carinii pneumonia.
    Clin Pharm; 1993 Mar; 12(3):175-6. PubMed ID: 8491073
    [No Abstract]   [Full Text] [Related]  

  • 18. Prophylaxis and therapy for Pneumocystis pneumonia--where are we?
    Masur H
    Infect Agents Dis; 1992 Oct; 1(5):270-8. PubMed ID: 1344666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group.
    El-Sadr WM; Murphy RL; Yurik TM; Luskin-Hawk R; Cheung TW; Balfour HH; Eng R; Hooton TM; Kerkering TM; Schutz M; van der Horst C; Hafner R
    N Engl J Med; 1998 Dec; 339(26):1889-95. PubMed ID: 9862944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment IND protocol announced for Pneumocystis carinii pneumonia.
    Clin Pharm; 1992 Feb; 11(2):99, 103. PubMed ID: 1551304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.